000 01310 a2200397 4500
005 20250513083859.0
264 0 _c19960213
008 199602s 0 0 eng d
022 _a0196-9781
024 7 _a10.1016/0196-9781(95)02013-m
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJosselyn, S A
245 0 0 _aThe CCKB antagonist, L-365,260, attenuates fear-potentiated startle.
_h[electronic resource]
260 _bPeptides
_c1995
300 _a1313-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnxiety
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aBenzodiazepinones
_xpharmacology
650 0 4 _aEmotions
_xdrug effects
650 0 4 _aFear
_xdrug effects
650 0 4 _aMale
650 0 4 _aPhenylurea Compounds
650 0 4 _aRats
650 0 4 _aReceptor, Cholecystokinin B
650 0 4 _aReceptors, Cholecystokinin
_xantagonists & inhibitors
650 0 4 _aReflex, Startle
_xdrug effects
700 1 _aFrankland, P W
700 1 _aPetrisano, S
700 1 _aBush, D E
700 1 _aYeomans, J S
700 1 _aVaccarino, F J
773 0 _tPeptides
_gvol. 16
_gno. 7
_gp. 1313-5
856 4 0 _uhttps://doi.org/10.1016/0196-9781(95)02013-m
_zAvailable from publisher's website
999 _c8544355
_d8544355